ConductScience.org, home

Trial · NCT04402489

Results by group18

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Change From Baseline in Average Daily Sunlight Exposure Time (Minutes) to First Prodromal Symptom (Burning, Tingling, Itching, or Stinging) Associated With Sunlight Exposure Between 1 Hour Post Sunrise and 1 Hour Pre-sunset at Week 26 (Visit 7)
DBT ITT1 Placebo20.59Standard Error 10.29minute
Change From Baseline in Average Daily Sunlight Exposure Time (Minutes) to First Prodromal Symptom (Burning, Tingling, Itching, or Stinging) Associated With Sunlight Exposure Between 1 Hour Post Sunrise and 1 Hour Pre-sunset at Week 26 (Visit 7)
DBT ITT1 MT- 7117 Low Dose30.39Standard Error 10.04minute
Change From Baseline in Average Daily Sunlight Exposure Time (Minutes) to First Prodromal Symptom (Burning, Tingling, Itching, or Stinging) Associated With Sunlight Exposure Between 1 Hour Post Sunrise and 1 Hour Pre-sunset at Week 26 (Visit 7)
DBT ITT1 MT- 7117 High Dose43.29Standard Error 10.13minute
Patient Global Impression of Change (PGIC) at Week 26DBT ITT1 Placebo3.25Standard Error 1.14point
Patient Global Impression of Change (PGIC) at Week 26DBT ITT1 MT- 7117 Low Dose2.41Standard Error 0.14point
Patient Global Impression of Change (PGIC) at Week 26DBT ITT1 MT- 7117 High Dose1.82Standard Error 0.14point
Total Number of Sunlight-induced Pain Events Defined as Prodrome Symptoms (Burning, Tingling, Itching, or Stinging) With Pain Rating of 1-10 on the Likert Scale During the 26-week Double-blind Treatment Period.
DBT ITT1 Placebo23.9Standard Deviation 30.93events
Total Number of Sunlight-induced Pain Events Defined as Prodrome Symptoms (Burning, Tingling, Itching, or Stinging) With Pain Rating of 1-10 on the Likert Scale During the 26-week Double-blind Treatment Period.
DBT ITT1 MT- 7117 Low Dose15.87Standard Deviation 22.05events
Total Number of Sunlight-induced Pain Events Defined as Prodrome Symptoms (Burning, Tingling, Itching, or Stinging) With Pain Rating of 1-10 on the Likert Scale During the 26-week Double-blind Treatment Period.
DBT ITT1 MT- 7117 High Dose13.78Standard Deviation 18.7events
Change From Baseline for Total Score in the Domain of Pain Intensity in the PROMIS-57 at Week 26DBT ITT1 Placebo-1.42Standard Error 0.18total score
Change From Baseline for Total Score in the Domain of Pain Intensity in the PROMIS-57 at Week 26DBT ITT1 MT- 7117 Low Dose-1.56Standard Error 0.16total score
Change From Baseline for Total Score in the Domain of Pain Intensity in the PROMIS-57 at Week 26DBT ITT1 MT- 7117 High Dose-1.65Standard Error 0.17total score
The Percentage of Subjects Who Are RespondersDBT ITT1 Placebo12percentage of participants
The Percentage of Subjects Who Are RespondersDBT ITT1 MT- 7117 Low Dose11percentage of participants
The Percentage of Subjects Who Are RespondersDBT ITT1 MT- 7117 High Dose16percentage of participants
Change From Baseline for Total Score in the Domain of Physical Function in the PROMIS-57 at Week 26DBT ITT1 Placebo0.67Standard Error 0.36total score
Change From Baseline for Total Score in the Domain of Physical Function in the PROMIS-57 at Week 26DBT ITT1 MT- 7117 Low Dose1.54Standard Error 0.32total score
Change From Baseline for Total Score in the Domain of Physical Function in the PROMIS-57 at Week 26DBT ITT1 MT- 7117 High Dose1.22Standard Error 0.33total score

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04402489/results